Mesenchymal Stromal Cells Combined With Elastin-Like Recombinamers Increase Angiogenesis In Vivo After Hindlimb Ischemia

Hindlimb ischemia is an unmet medical need, especially for those patients unable to undergo vascular surgery. Cellular therapy, mainly through mesenchymal stromal cell (MSC) administration, may be a potentially attractive approach in this setting. In the current work, we aimed to assess the potentia...

Descrición completa

Detalles Bibliográficos

Principais autores:	Arturo Ibáñez-Fonseca, Ana Rico, Silvia Preciado, Fernando González-Pérez, Sandra Muntión, Jesús García-Briñón, María-Carmen García-Macías, José Carlos Rodríguez-Cabello, Miguel Pericacho, Matilde Alonso, Fermín Sánchez-Guijo
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Bioengineering and Biotechnology
Assuntos:	mesenchymal stromal cells biomaterials elastin-like recombinamers hindlimb ischemia angiogenesis mesenchymal stem cells
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fbioe.2022.918602/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!